help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asou, Y.
Right arrow Articles by Noda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asou, Y.
Right arrow Articles by Noda, M.
Endocrinology Vol. 142, No. 3 1325-1332
Copyright © 2001 by The Endocrine Society


ARTICLES

Osteopontin Facilitates Angiogenesis, Accumulation of Osteoclasts, and Resorption in Ectopic Bone1

Yoshinori Asou, Susan R. Rittling, Hiroyuki Yoshitake, Kunikazu Tsuji, Kenichi Shinomiya, Akira Nifuji, David T. Denhardt and Masaki Noda

Department of Molecular Pharmacology, Medical Research Institute (Y.A., H.Y., K.T., A.N., M.N.), and Department of Orthopedic Surgery (K.S.), Tokyo Medical and Dental University, Tokyo 101-0062, Japan; and Department of Cell Biology and Neuroscience, Rutgers University (S.R.R., D.T.D.), Piscataway, New Jersey 08854

Address all correspondence and requests for reprints to: Masaki Noda, M.D., Ph.D., Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, 2–3-10 Kanda, Surugadai Chiyoda-ku, Tokyo, Japan. E-mail: noda.mph{at}mri.tmd.ac.jp

Osteoclastic bone resorption requires a number of complex steps that are under the control of local regulatory molecules. Osteopontin is expressed in osteoclasts and is also present in bone matrix; however, its biological function has not been fully understood. To elucidate the role of osteopontin in the process of osteoclastic bone resorption, we conducted ectopic bone implantation experiments using wild-type and osteopontin knockout mouse. In the wild-type group, bone discs from calvariae implanted ectopically in muscle were resorbed, and their mass was reduced by 25% within 4 weeks. In contrast, the mass of the bone discs from calvariae of osteopontin knockout mice was reduced by only 5% when implanted in osteopontin knockout mice. Histological analyses indicated that the number of osteoclasts associated with the implanted bones was reduced in the osteopontin knockout mice. As osteopontin deficiency does not suppress osteoclastogenesis per se, we further examined vascularization immunohistologically and found that the number of vessels containing CD31-positive endothelial cells around the bone discs implanted in muscle was reduced in the osteopontin knockout mice. Furthermore, sc implantation assays indicated that the length and branching points of the newly formed vasculatures associated with the bone discs were also reduced in the absence of osteopontin. In this assay, tartrate-resistant acid phosphatase-positive area of the bone discs was also reduced in the osteopontin knockout mice, indicating further the link between the osteopontin-dependent vascularization and osteoclast accumulation. The bone resorption defect could be rescued by topical administration of recombinant osteopontin to the bones implanted in muscle. These observations indicate that osteopontin is required for efficient vascularization by the hemangiogenic endothelial cells and subsequent osteoclastic resorption of bones.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Lam Shang Leen, C. Filipe, A. Billon, B. Garmy-Susini, S. Jalvy, F. Robbesyn, D. Daret, C. Allieres, S. R. Rittling, N. Werner, et al.
Estrogen-Stimulated Endothelial Repair Requires Osteopontin
Arterioscler. Thromb. Vasc. Biol., December 1, 2008; 28(12): 2131 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden
Migratory neighbors and distant invaders: tumor-associated niche cells
Genes & Dev., March 1, 2008; 22(5): 559 - 574.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Ishijima, K. Tsuji, S. R Rittling, T. Yamashita, H. Kurosawa, D. T Denhardt, A. Nifuji, Y. Ezura, and M. Noda
Osteopontin is required for mechanical stress-dependent signals to bone marrow cells
J. Endocrinol., May 1, 2007; 193(2): 235 - 243.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Kolanczyk, N. Kossler, J. Kuhnisch, L. Lavitas, S. Stricker, U. Wilkening, I. Manjubala, P. Fratzl, R. Sporle, B. G. Herrmann, et al.
Multiple roles for neurofibromin in skeletal development and growth
Hum. Mol. Genet., April 15, 2007; 16(8): 874 - 886.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Tanaka, M. Abe, M. Hiasa, A. Oda, H. Amou, A. Nakano, K. Takeuchi, K. Kitazoe, S. Kido, D. Inoue, et al.
Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin
Clin. Cancer Res., February 1, 2007; 13(3): 816 - 823.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Naldini, D. Leali, A. Pucci, E. Morena, F. Carraro, B. Nico, D. Ribatti, and M. Presta
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes
J. Immunol., October 1, 2006; 177(7): 4267 - 4270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Shen and S. Christakos
The Vitamin D Receptor, Runx2, and the Notch Signaling Pathway Cooperate in the Transcriptional Regulation of Osteopontin
J. Biol. Chem., December 9, 2005; 280(49): 40589 - 40598.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Nilsson, H. M. Johnston, G. A. Whitty, B. Williams, R. J. Webb, D. T. Denhardt, I. Bertoncello, L. J. Bendall, P. J. Simmons, and D. N. Haylock
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells
Blood, August 15, 2005; 106(4): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. E. Davis, P. C.H. Hsieh, A. J. Grodzinsky, and R. T. Lee
Custom Design of the Cardiac Microenvironment With Biomaterials
Circ. Res., July 8, 2005; 97(1): 8 - 15.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G.D.M. Collett and A.E. Canfield
Angiogenesis and Pericytes in the Initiation of Ectopic Calcification
Circ. Res., May 13, 2005; 96(9): 930 - 938.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-A. Renault, S. Jalvy, M. Potier, I. Belloc, E. Genot, L. V. Dekker, C. Desgranges, and A.-P. Gadeau
UTP Induces Osteopontin Expression through a Coordinate Action of NF{kappa}B, Activator Protein-1, and Upstream Stimulatory Factor in Arterial Smooth Muscle Cells
J. Biol. Chem., January 28, 2005; 280(4): 2708 - 2713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Abe, K. Hiura, J. Wilde, A. Shioyasono, K. Moriyama, T. Hashimoto, S. Kido, T. Oshima, H. Shibata, S. Ozaki, et al.
Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion
Blood, October 15, 2004; 104(8): 2484 - 2491.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. Kojima, T. Uede, and T. Uemura
In Vitro and In Vivo Effects of the Overexpression of Osteopontin on Osteoblast Differentiation Using a Recombinant Adenoviral Vector
J. Biochem., September 1, 2004; 136(3): 377 - 386.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Gattorno, A. Gregorio, F. Ferlito, V. Gerloni, A. Parafioriti, E. Felici, E. Sala, C. Gambini, P. Picco, and A. Martini
Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis
Rheumatology, September 1, 2004; 43(9): 1091 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Endocr. Rev., August 1, 2004; 25(4): 629 - 672.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Abedin, Y. Tintut, and L. L. Demer
Vascular Calcification: Mechanisms and Clinical Ramifications
Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1161 - 1170.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. O'Gradaigh and J. E. Compston
T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion
Rheumatology, February 1, 2004; 43(2): 122 - 130.
[Full Text] [PDF]


Home page
BloodHome page
A. Vacca, R. Ria, F. Semeraro, F. Merchionne, M. Coluccia, A. Boccarelli, C. Scavelli, B. Nico, A. Gernone, F. Battelli, et al.
Endothelial cells in the bone marrow of patients with multiple myeloma
Blood, November 1, 2003; 102(9): 3340 - 3348.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Leali, P. Dell'Era, H. Stabile, B. Sennino, A. F. Chambers, A. Naldini, S. Sozzani, B. Nico, D. Ribatti, and M. Presta
Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
J. Immunol., July 15, 2003; 171(2): 1085 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Hirata, S. Masuda, T. Tamura, K. Kai, K. Ojima, A. Fukase, K. Motoyoshi, K. Kamakura, Y. Miyagoe-Suzuki, and S.'i. Takeda
Expression Profiling of Cytokines and Related Genes in Regenerating Skeletal Muscle after Cardiotoxin Injection: A Role for Osteopontin
Am. J. Pathol., July 1, 2003; 163(1): 203 - 215.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Myers, K. J. Harmon, V. Lindner, and L. Liaw
Alterations of Arterial Physiology in Osteopontin-Null Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 1021 - 1028.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Y. Speer, M. D. McKee, R. E. Guldberg, L. Liaw, H.-Y. Yang, E. Tung, G. Karsenty, and C. M. Giachelli
Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein-deficient Mice: Evidence for Osteopontin as an Inducible Inhibitor of Vascular Calcification In Vivo
J. Exp. Med., October 21, 2002; 196(8): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Yumoto, M. Ishijima, S. R. Rittling, K. Tsuji, Y. Tsuchiya, S. Kon, A. Nifuji, T. Uede, D. T. Denhardt, and M. Noda
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice
PNAS, April 2, 2002; 99(7): 4556 - 4561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson
Acid phosphatases
Mol. Pathol., April 1, 2002; 55(2): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Yang, S. J. Hyllner, and S. Christakos
Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E162 - E170.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society